have a vital role to play in cancer care, particularly as treatments become ever more complex, a new position statement from the European Society for Medical Oncology says.
As shown in Table 2b, 16 or the 20 patients (80%) agreed or strongly agreed that their treating oncologist
was comfortable having a discussion on EOL issues; 3 (15%) responded neutral, and only one person strongly disagreed with this statement.
It would certainly appear that diagnosing advanced cancer based solely on an unproven blood test, and prescribing an expensive and unproven treatment without first recommending a referral to an oncologist
, smacks of gross incompetence or fraud.
During his chemotherapy treatments, Steve talked to the oncologist
about the Gerson Therapy, but the doctor was not supportive of Dr.
finish their training in ob/gyn and then train for another two- to four-years in all aspects of gynecologic cancers, including epidemiology, diagnosis, screening and how to combine surgical, chemotherapeutic and radiation therapies to improve survival.
Profiling may eventually help oncologists
select the best drugs for treatment.
Current positions: Director, chief executive officer and attending oncologist
Personalised Medicines in Oncology : Assessing Key Drivers and Challenges at the Physician Level (US) is based on survey results from 50 US oncologists
(33 medical oncologists
and 17 haematologist-oncologists
) and offers insights on what oncologists
believe are the critical issues, challenges and opportunities within the personalised medicines space, and how oncologists
intend to adopt personalised medicine in the future.
When the investigators looked at visits to a radiation oncologist
or a urologist, they found 80% of men had two follow-up visits and 91% had one visit.
Since most oncologists
have not administered [abdominal] chemotherapy," Burger says.
It is true that we do not employ a medical oncologist
Report Features Filled with charts and up-to-the-minute survey analysis, this report offers: Precise and timely analysis of EU5 oncologist
awareness, perception of value, promise and benefits of personalised medicine Data and insight on current usage and access status, and challenges related to personalised medicine access and adoption intention EU5 Oncologist
views on the critical enablers and success factors of personalised medicine, as well as anticipated future developments About the Survey Interview Methodology Data was collected via a 10-minute internet-based questionnaire Sample 150 oncologists
(104 medical oncologists
and 46 haematologist-oncologists
) in France, Germany, Spain, Italy and the UK.